Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metalloenzymes and metalloproteins requiring Zn²⁺ or Cu²⁺ represent a diverse and essential class of proteins that utilize metal ions as critical cofactors for biological activity. Zinc-dependent enzymes, such as carbonic anhydrases and matrix metalloproteinases (MMPs), are involved in a wide range of processes including pH regulation, tissue remodeling, and protein degradation (McCall et al., 2000, Journal of Nutrition). Copper-dependent proteins, including superoxide dismutase and cytochrome c oxidase, are vital for antioxidant defense and cellular energy production (Uauy et al., 1998, American Journal of Clinical Nutrition). These proteins are significant therapeutic targets; for instance, angiotensin-converting enzyme (ACE) is a primary target for treating hypertension, while MMPs are investigated in cancer and inflammatory diseases (Fingleton, 2008, Expert Opinion on Therapeutic Targets). Drugs targeting these molecules typically act by binding directly to the metal ion in the active site, thereby blocking substrate access or catalytic turnover (Patchett et al., 1980, Nature). However, the structural similarity of metal-binding sites across different enzyme families presents a major challenge for achieving drug selectivity and avoiding systemic toxicity (Vallee & Auld, 1990, Biochemistry).
Inhibition of enzymatic activity through coordination with the metal ion in the active site or through the chelation of essential metal cofactors.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metalloenzymes and metalloproteins requiring Zn²⁺ or Cu²⁺.